TriSalus Life Sciences Inc. (TLSI) — Financial Flexibility Index
TriSalus Life Sciences Inc. (TLSI) has a Financial Flexibility Index of -0.06x as of September 2025. Free cash flow of $-3.49 Million (operating CF $-3.71 Million minus capex $216.00K) represents 0% of total liabilities ($63.19 Million). Check TriSalus Life Sciences Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TriSalus Life Sciences Inc. Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for TriSalus Life Sciences Inc. across 4 annual periods. See TLSI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for TriSalus Life Sciences Inc. (2021–2024)
Year-by-year free cash flow to debt coverage for TriSalus Life Sciences Inc.. For the full company profile including market capitalisation, see market value of TriSalus Life Sciences Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.81x | $-40.50 Million | $-40.84 Million | $49.87 Million | ▲ +16.1% |
| 2023 | -0.97x | $-49.99 Million | $-50.58 Million | $51.66 Million | ▼ -5.3% |
| 2022 | -0.92x | $-31.53 Million | $-32.31 Million | $34.32 Million | ▲ +70.3% |
| 2021 | -3.09x | $-21.44 Million | $-22.70 Million | $6.93 Million | — |